These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24893994)

  • 1. Candesartan cilexetil microemulsions for transdermal delivery: formulation, in-vitro skin permeation and stability assessment.
    Malakar J; Basu A; Nayak AK
    Curr Drug Deliv; 2014; 11(3):313-21. PubMed ID: 24893994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
    AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
    Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.
    Sezgin-Bayindir Z; Antep MN; Yuksel N
    AAPS PharmSciTech; 2015 Feb; 16(1):108-17. PubMed ID: 25204859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
    Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
    Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan.
    Musko M; Sznitowska M
    Acta Pharm; 2014 Dec; 64(4):463-74. PubMed ID: 25531786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of polysorbate 20 on solubility and stability of candesartan cilexetil in dissolution media.
    Hoppe K; Sznitowska M
    AAPS PharmSciTech; 2014 Oct; 15(5):1116-25. PubMed ID: 24871550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of microemulsion systems for dermal delivery of silymarin.
    Panapisal V; Charoensri S; Tantituvanont A
    AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of sinomenine microemulsion and its transdermal absorption].
    Zhang XZ; Zhu HD; Meng SF; Pan XG
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2007-10. PubMed ID: 18161292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
    Ugurlu T; Nalbantoglu A; Sengel-Turk CT
    Acta Pol Pharm; 2016 Nov; 73(6):1631-1638. PubMed ID: 29634119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of microemulsions of suitable viscosity for cyclosporine skin delivery.
    Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S
    Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
    Surampalli G; Nanjwade BK; Patil PA; Chilla R
    Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor.
    Gurunath S; Nanjwade BK; Patil PA
    Drug Dev Ind Pharm; 2015 Jan; 41(1):170-6. PubMed ID: 24168234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid self-microemulsifying formulation for candesartan cilexetil.
    Nekkanti V; Karatgi P; Prabhu R; Pillai R
    AAPS PharmSciTech; 2010 Mar; 11(1):9-17. PubMed ID: 20013081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Water in oil microemulsions containing NaCl for transdermal delivery of fluorouracil].
    Xiao YY; Liu F; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2011 Jun; 46(6):720-6. PubMed ID: 21882535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsion systems to enhance the transdermal permeation of ivermectin in dogs: A preliminary in vitro study.
    Machado M; Dantas IL; Galvão JG; Lima AD; Gonsalves JKMDC; Almeida EDP; de Araujo GRS; Leal LB; Sarmento VHV; Nunes RS; Lira AAM
    Res Vet Sci; 2020 Dec; 133():31-38. PubMed ID: 32920349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adapalene microemulsion for transfollicular drug delivery.
    Bhatia G; Zhou Y; Banga AK
    J Pharm Sci; 2013 Aug; 102(8):2622-31. PubMed ID: 23728912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Pharmaceutical Evaluation of Candesartan and Candesartan Cilexetil: Physicochemical Properties, In Vitro Dissolution and Ex Vivo In Vivo Studies.
    Amer AM; Allam AN; Abdallah OY
    AAPS PharmSciTech; 2018 Feb; 19(2):661-667. PubMed ID: 28948575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
    Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
    Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.